A4C News
Rachel Splinter
Advocacy Alert: Angels for Change joins ...

Drug shortages affect real patients every single day—making reliable access to medication not just a goal, but a necessity. That’s why we’re proud to champion the patient voice in three important CMS comment letters focused on strengthening a more dependable and resilient drug supply.

At Angels for Change, advocacy is more than a mission—it’s action. By collaborating with leading partners such as the Duke-Margolis Institute for Health Policy, the End Drug Shortages Alliance (EDSA), and the U.S. Pharmacopeia Drug Shortage Task Force, we’re helping drive solutions that are both practical and firmly rooted in the real needs of patients.

Advocacy Alert: Angels for Change joins Industry Leaders in Official Comment Letters to CMS
A4C News, Newsletter
Rachel Splinter
Change Maker Chronicle: The March Forth Edition

The newest Change Maker Chronicle is here! Drug shortages are still impacting patients every day, but together we are pushing forward. See how we’re raising awareness, fostering advocacy, and building resilent drug supply chains to end drug shortages NOW.

Change Maker Chronicle: The March Forth Edition
Press Release, A4C News
Rachel Splinter
Project PROTECT Milestone: U.S. Supply of ...

Angels for Change is proud to announce a major Project PROTECT milestone: our partner Fagron Sterile Services is now fully production-ready with new U.S. capacity for Sterile Water for Injection—a critical component used in countless injectable medicines.

This marks the second successful Project PROTECT collaboration with Fagron, following earlier investments that helped protect patients during the IV fluid shortage in 2024. By investing in domestic manufacturing infrastructure, we’re strengthening the resilience of the U.S. drug supply and protecting patients before shortages occur.

We don’t just talk about ending drug shortages—we’re creating solutions that build onshore readiness, strengthen supply chains, and protect patient access to lifesaving medicines.

Project PROTECT Milestone: U.S. Supply of Sterile Water for Injection Protected
In the News
Rachel Splinter
Laura Bray Featured in APIIC White Paper on ...

Laura Bray and Angels for Change highlighted in the newly released white paper from the API Innovation Center, “Fragility to Resilience: Aligning Investment and Purchasing to Secure America’s Drug Supply Chain.”

Bray emphasized a clear call to action for leaders across the healthcare ecosystem to work together to solve the drug shortage crisis:

“This is not the patient’s job to solve at all… This is a supply chain failure.”

Laura Bray Featured in APIIC White Paper on Strengthening the Drug Supply Chain
Rachel Splinter
Angels for Change and Project GOLD highlighted ...

Drug shortages are making national headlines again as families search for critical medicines like leucovorin. In a recent CNN article, Angels for Change founder Laura Bray highlights how the crisis was predictable—and preventable. Through Project GOLD, Angels for Change works across the supply chain to locate scarce medications and help patients access the treatments they depend on, because no family should have to face a shortage alone.

Angels for Change and Project GOLD highlighted in CNN article about the current Leucovorin Drug Shortage in the U.S.

Advocacy Alert: Angels for Change joins Industry Leaders in Official Comment Letters to CMS

Advocacy Alert: Angels for Change joins Industry Leaders in Official Comment Letters to CMS

Drug shortages affect real patients every single day—making reliable access to medication not just a goal, but a necessity. That’s why we’re proud to champion the patient voice in three important CMS comment letters focused on strengthening a more dependable and resilient drug supply.

At Angels for Change, advocacy is more than a mission—it’s action. By collaborating with leading partners such as the Duke-Margolis Institute for Health Policy, the End Drug Shortages Alliance (EDSA), and the U.S. Pharmacopeia Drug Shortage Task Force, we’re helping drive solutions that are both practical and firmly rooted in the real needs of patients.

,

Project PROTECT Milestone: U.S. Supply of Sterile Water for Injection Protected

,
Project PROTECT Milestone: U.S. Supply of Sterile Water for Injection Protected

Angels for Change is proud to announce a major Project PROTECT milestone: our partner Fagron Sterile Services is now fully production-ready with new U.S. capacity for Sterile Water for Injection—a critical component used in countless injectable medicines.

This marks the second successful Project PROTECT collaboration with Fagron, following earlier investments that helped protect patients during the IV fluid shortage in 2024. By investing in domestic manufacturing infrastructure, we’re strengthening the resilience of the U.S. drug supply and protecting patients before shortages occur.

We don’t just talk about ending drug shortages—we’re creating solutions that build onshore readiness, strengthen supply chains, and protect patient access to lifesaving medicines.

Laura Bray Featured in APIIC White Paper on Strengthening the Drug Supply Chain

Laura Bray Featured in APIIC White Paper on Strengthening the Drug Supply Chain

Laura Bray and Angels for Change highlighted in the newly released white paper from the API Innovation Center, “Fragility to Resilience: Aligning Investment and Purchasing to Secure America’s Drug Supply Chain.”

Bray emphasized a clear call to action for leaders across the healthcare ecosystem to work together to solve the drug shortage crisis:

“This is not the patient’s job to solve at all… This is a supply chain failure.”

Angels for Change and Project GOLD highlighted in CNN article about the current Leucovorin Drug Shortage in the U.S.

Angels for Change and Project GOLD highlighted in CNN article about the current Leucovorin Drug Shortage in the U.S.

Drug shortages are making national headlines again as families search for critical medicines like leucovorin. In a recent CNN article, Angels for Change founder Laura Bray highlights how the crisis was predictable—and preventable. Through Project GOLD, Angels for Change works across the supply chain to locate scarce medications and help patients access the treatments they depend on, because no family should have to face a shortage alone.

Angels for Change serves as Advising Member in the Drug Resiliency & Transparency Pilot

Angels for Change serves as Advising Member in the Drug Resiliency & Transparency Pilot

At Angels for Change, we are proud to participate in the important work of the End Drug Shortages Alliance — serving as both an EDSA member organization and advising partner in the Drug Resiliency & Transparency Pilot.

The initial phase of the pilot demonstrated a powerful truth: when leaders come together early through trusted, neutral governance, transparency delivers real planning value.

,

Project PROTECT Milestone: Angels for Change and Mark Cuban Cost Plus Drug Company have Strengthened the U.S. Supply of Carboplatin & Methotrexate

,
Project PROTECT Milestone: Angels for Change and Mark Cuban Cost Plus Drug Company have Strengthened the U.S. Supply of Carboplatin & Methotrexate

Angels for Change today announced that the Mark Cuban Cost Plus Drug Company has completed the Preparation and Protective phases of Project PROTECT for Carboplatin Injection and Methotrexate Injection—two essential oncology medicines currently in nationwide shortage. This milestone strengthens onshore readiness and improves supply availability for patients across the United States.

The Warriors behind the Drug Shortage Crisis: A Capitol Hill Briefing

The Warriors behind the Drug Shortage Crisis: A Capitol Hill Briefing

Drug shortages are not just a supply chain problem—they are personal. In this Capitol Hill briefing hosted by U.S. Pharmacopeia (USP), patients share firsthand how medication shortages have disrupted care, created fear and uncertainty, and put lives at risk. Their stories underscore the urgent need for stronger policies, better transparency, and a more resilient drug supply system—because patients are counting on us.

Angels for Change Convenes First Ever SummitONE PolicyLAB to Drive Action on the U.S. Drug Shortage Crisis

Angels for Change Convenes First Ever SummitONE PolicyLAB to Drive Action on the U.S. Drug Shortage Crisis

New from Angels for Change: the launch of our Policy Lab.

The A4C Policy Lab brings together patients, clinicians, policymakers, and industry leaders to turn frontline experience into actionable policy solutions that address drug shortages at their root.

Last week on January 29th, 2026, Angels for Change convened a sold-out National Policy Lab on Capitol Hill in the historic Kennedy Caucus Room to tackle one of the most urgent issues in healthcare: the U.S. drug shortage crisis.

Angels for Change is translating patient harm into real-world policy solutions. This Policy Lab wasn’t a conference — it was a working session focused on collaboration, candor, and outcomes, with patients at the center of every solution.

2025 Year in Review

2025 Year in Review

Angels for Change — 2025 Year in Review

From supporting patients through dozens of different shortage crisis to launching a first-of-its-kind oncology resiliency program to shaping national policy conversations, 2025 was a year of bold action and patient-driven progress.

Together with partners across healthcare, government, and industry, we:

  • Protected patients during critical drug shortages

  • Launched Project GOLD to proactively safeguard cancer care

  • Protected 4 addition essential medicines for the American people with Project PROTECT 

  • Elevated patient voices in policy and supply chain reform

  • Built momentum toward a more resilient medicine supply system

See how collaboration, transparency, and patient leadership are driving lasting change.

SHARE YOUR “WHY”

Every conversation, partnership, and shared story brings us closer to a future without drug shortages. At Angels for Change, we’re proud to march forth for patients everywhere.

SHARE YOUR STORY